Legislative, Regulatory & Legal

AAM files amicus brief supporting biosimilars pathway
An Association for Accessible Medicines amicus brief argues that even if the individual mandate of the Affordable Care Act is deemed unconstitutional, the biosimilars pathway should remain intact.
HRG, PHT complete small dispenser DSCSA pilot study
The Drug Supply Chain Security Act pilot study underscored that most pharmacists were unaware of many of the requirements and needed assistance in carrying out best practice and process implementation.

NCPA joins push for additional economic recovery assistance

NCPA is joining the America’s Recovery Fund Coalition, which is advocating for longer-term federal support for businesses and pharmacies.
California now allowing pharmacist testing for COVID-19

California's Department of Consumer Affairs is issuing a waiver authorizing pharmacists to order and administer COVID-19 tests, drawing praise from industry organizations.
NCPA survey: Independent pharmacists want Congress to protect essential businesses from lawsuits

Nearly three-quarters of independent pharmacists fear being dragged into court over coronavirus, according to an NCPA’s survey.
Sephora, JCPenney to continue partnership

The long-standing partnership to operate Sephora inside JCPenney has been reaffirmed by both companies.
Patient groups call on Congress for DIR fee reform

More than 240 patient advocates and healthcare entities are urging members of Congress to address DIR fee reforms this year.
AbbVie's acquisition of Allergan approved by High Court of Ireland

The High Court of Ireland has approved the acquisition of Allergan by AbbVie by means of a scheme of arrangement that is expected to take place May 8.
How NACDS is supporting the industry during the pandemic

Steve Anderson, president and CEO of NACDS, discusses how the organization is showing its support for the industry amid the ongoing COVID-19 pandemic.
Second Source Rx earns NABP Drug Distributor Accreditation

To earn NABP's Drug Distributor Accreditation, Second Source Rx had to demonstrate its commitment to preventing counterfeit drugs from entering the U.S. drug supply.

Legislative, Regulatory & Legal

AAM files amicus brief supporting biosimilars pathway

HRG, PHT complete small dispenser DSCSA pilot study

NCPA joins push for additional economic recovery assistance

California now allowing pharmacist testing for COVID-19

NCPA survey: Independent pharmacists want Congress to protect essential businesses from lawsuits

Sephora, JCPenney to continue partnership

Patient groups call on Congress for DIR fee reform

AbbVie's acquisition of Allergan approved by High Court of Ireland

How NACDS is supporting the industry during the pandemic

Second Source Rx earns NABP Drug Distributor Accreditation